EVALUATION OF PROGNOSTIC FACTORS IN PATIENTS WITH RELAPSED HODGKIN’S LYMPHOMA UNDERGOING AUTOLOGOUS STEM CELL TRANSPLANT

Objective: To identify the prognostic factors in relapsed Hodgkin’s Lymphoma patients with regards to their impact on the outcome of autologous hematopoietic stem cell transplant. Study Design: Retrospective observational study. Place and Duration of Study: Department of Medical Oncology, Shau...

Full description

Bibliographic Details
Main Authors: Jhanzeb Iftikhar, Hafiz Abubakar Sarwar, Fareeha Sheikh, Mohammad Iqbal Shah, Shafqual Ali Khan, Muhammad Abu Bakar, Neelam Siddiqui
Format: Article
Language:English
Published: Army Medical College Rawalpindi 2021-10-01
Series:Pakistan Armed Forces Medical Journal
Subjects:
Online Access:https://www.pafmj.org/index.php/PAFMJ/article/view/4132/3632
_version_ 1818823138311405568
author Jhanzeb Iftikhar
Hafiz Abubakar Sarwar
Fareeha Sheikh
Mohammad Iqbal Shah
Shafqual Ali Khan
Muhammad Abu Bakar
Neelam Siddiqui
author_facet Jhanzeb Iftikhar
Hafiz Abubakar Sarwar
Fareeha Sheikh
Mohammad Iqbal Shah
Shafqual Ali Khan
Muhammad Abu Bakar
Neelam Siddiqui
author_sort Jhanzeb Iftikhar
collection DOAJ
description Objective: To identify the prognostic factors in relapsed Hodgkin’s Lymphoma patients with regards to their impact on the outcome of autologous hematopoietic stem cell transplant. Study Design: Retrospective observational study. Place and Duration of Study: Department of Medical Oncology, Shaukat Khanum Memorial Cancer Hospital & Research Center, Lahore, Jun 1999 to Jun 2019. Methodology: Out of a total of 2061 Hodgkin’s Lymphoma patients, 37 (1.8%) patients with relapsed disease underwent autotransplant and were studied using the Hospital Information System. We obtained details of clinicopathological factors, treatment, and outcome. In our study, the outcome variable was event after transplant (relapse/disease progression/death). Results: Among the 37 relapsed Hodgkin’s Lymphoma patients undergoing auto-transplant, 24 (64.9%) patients had an early relapse after first-line chemotherapy. In this early relapse group of 24 patients, 9 (37.5%) remained well after auto-transplant but 15 (62.5%) patients had an event. Out of 37 relapsed Hodgkin’s Lymphoma patients undergoing auto-transplant, a complete response on pre-transplant imaging was observed in 24 (64.9%) patients. In those 24 patients with a complete response on pre-transplant imaging, 16 (66.7%) patients remained well after transplant while 8 (33.3%) patients had a worse event. Twoyear progression-free and overall survival proportions were 56% and 77% respectively. Conclusion: Complete metabolic response on pre-transplant imaging was associated with better overall survival. Adverse factors observed were initial short duration of complete response, bulky disease at relapse, variables comprising international prognostic score, B symptoms, and raised erythrocyte sedimentation rate at relapse.
first_indexed 2024-12-18T23:35:13Z
format Article
id doaj.art-a6666984a311421ea81f23ba7079fa44
institution Directory Open Access Journal
issn 0030-9648
2411-8842
language English
last_indexed 2024-12-18T23:35:13Z
publishDate 2021-10-01
publisher Army Medical College Rawalpindi
record_format Article
series Pakistan Armed Forces Medical Journal
spelling doaj.art-a6666984a311421ea81f23ba7079fa442022-12-21T20:47:35ZengArmy Medical College RawalpindiPakistan Armed Forces Medical Journal0030-96482411-88422021-10-0171518331838EVALUATION OF PROGNOSTIC FACTORS IN PATIENTS WITH RELAPSED HODGKIN’S LYMPHOMA UNDERGOING AUTOLOGOUS STEM CELL TRANSPLANTJhanzeb Iftikhar0Hafiz Abubakar Sarwar1Fareeha Sheikh2Mohammad Iqbal Shah3Shafqual Ali Khan4Muhammad Abu Bakar5Neelam Siddiqui6Shaukat Khanum Memorial Cancer Hospital & Research Center, Lahore PakistanShaukat Khanum Memorial Cancer Hospital & Research Center, Lahore PakistanShaukat Khanum Memorial Cancer Hospital & Research Center, Lahore PakistanShaukat Khanum Memorial Cancer Hospital & Research Center, Lahore PakistanShaukat Khanum Memorial Cancer Hospital & Research Center, Lahore PakistanShaukat Khanum Memorial Cancer Hospital & Research Center, Lahore PakistanShaukat Khanum Memorial Cancer Hospital & Research Center, Lahore PakistanObjective: To identify the prognostic factors in relapsed Hodgkin’s Lymphoma patients with regards to their impact on the outcome of autologous hematopoietic stem cell transplant. Study Design: Retrospective observational study. Place and Duration of Study: Department of Medical Oncology, Shaukat Khanum Memorial Cancer Hospital & Research Center, Lahore, Jun 1999 to Jun 2019. Methodology: Out of a total of 2061 Hodgkin’s Lymphoma patients, 37 (1.8%) patients with relapsed disease underwent autotransplant and were studied using the Hospital Information System. We obtained details of clinicopathological factors, treatment, and outcome. In our study, the outcome variable was event after transplant (relapse/disease progression/death). Results: Among the 37 relapsed Hodgkin’s Lymphoma patients undergoing auto-transplant, 24 (64.9%) patients had an early relapse after first-line chemotherapy. In this early relapse group of 24 patients, 9 (37.5%) remained well after auto-transplant but 15 (62.5%) patients had an event. Out of 37 relapsed Hodgkin’s Lymphoma patients undergoing auto-transplant, a complete response on pre-transplant imaging was observed in 24 (64.9%) patients. In those 24 patients with a complete response on pre-transplant imaging, 16 (66.7%) patients remained well after transplant while 8 (33.3%) patients had a worse event. Twoyear progression-free and overall survival proportions were 56% and 77% respectively. Conclusion: Complete metabolic response on pre-transplant imaging was associated with better overall survival. Adverse factors observed were initial short duration of complete response, bulky disease at relapse, variables comprising international prognostic score, B symptoms, and raised erythrocyte sedimentation rate at relapse.https://www.pafmj.org/index.php/PAFMJ/article/view/4132/3632autologous stem cell transplanthodgkin’s lymphoma
spellingShingle Jhanzeb Iftikhar
Hafiz Abubakar Sarwar
Fareeha Sheikh
Mohammad Iqbal Shah
Shafqual Ali Khan
Muhammad Abu Bakar
Neelam Siddiqui
EVALUATION OF PROGNOSTIC FACTORS IN PATIENTS WITH RELAPSED HODGKIN’S LYMPHOMA UNDERGOING AUTOLOGOUS STEM CELL TRANSPLANT
Pakistan Armed Forces Medical Journal
autologous stem cell transplant
hodgkin’s lymphoma
title EVALUATION OF PROGNOSTIC FACTORS IN PATIENTS WITH RELAPSED HODGKIN’S LYMPHOMA UNDERGOING AUTOLOGOUS STEM CELL TRANSPLANT
title_full EVALUATION OF PROGNOSTIC FACTORS IN PATIENTS WITH RELAPSED HODGKIN’S LYMPHOMA UNDERGOING AUTOLOGOUS STEM CELL TRANSPLANT
title_fullStr EVALUATION OF PROGNOSTIC FACTORS IN PATIENTS WITH RELAPSED HODGKIN’S LYMPHOMA UNDERGOING AUTOLOGOUS STEM CELL TRANSPLANT
title_full_unstemmed EVALUATION OF PROGNOSTIC FACTORS IN PATIENTS WITH RELAPSED HODGKIN’S LYMPHOMA UNDERGOING AUTOLOGOUS STEM CELL TRANSPLANT
title_short EVALUATION OF PROGNOSTIC FACTORS IN PATIENTS WITH RELAPSED HODGKIN’S LYMPHOMA UNDERGOING AUTOLOGOUS STEM CELL TRANSPLANT
title_sort evaluation of prognostic factors in patients with relapsed hodgkin s lymphoma undergoing autologous stem cell transplant
topic autologous stem cell transplant
hodgkin’s lymphoma
url https://www.pafmj.org/index.php/PAFMJ/article/view/4132/3632
work_keys_str_mv AT jhanzebiftikhar evaluationofprognosticfactorsinpatientswithrelapsedhodgkinslymphomaundergoingautologousstemcelltransplant
AT hafizabubakarsarwar evaluationofprognosticfactorsinpatientswithrelapsedhodgkinslymphomaundergoingautologousstemcelltransplant
AT fareehasheikh evaluationofprognosticfactorsinpatientswithrelapsedhodgkinslymphomaundergoingautologousstemcelltransplant
AT mohammadiqbalshah evaluationofprognosticfactorsinpatientswithrelapsedhodgkinslymphomaundergoingautologousstemcelltransplant
AT shafqualalikhan evaluationofprognosticfactorsinpatientswithrelapsedhodgkinslymphomaundergoingautologousstemcelltransplant
AT muhammadabubakar evaluationofprognosticfactorsinpatientswithrelapsedhodgkinslymphomaundergoingautologousstemcelltransplant
AT neelamsiddiqui evaluationofprognosticfactorsinpatientswithrelapsedhodgkinslymphomaundergoingautologousstemcelltransplant